-
-
-
-
-
-
-
Compass Pathways (CMPS) PT Raised to $22 at RBC Capital
-
-
-
-
-
-
-
COMPASS Pathways plc (CMPS) Misses Q4 EPS by 60c
-
-
-
-
-
-
-
Compass Pathways Announces FDA Acceptance of IND Application for PTSD
-
-
-
-
-
-
-
Compass Pathways (CMPS) PT Lowered to $40 at H.C. Wainwright
-
-
-
-
-
-
-
Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
-
-
-
-
-
-
-
COMPASS Pathways plc (CMPS) Tops Q3 EPS by 1c
-
-
-
-
-
-
-
Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business HighlightsÂ
-
1,216,192 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

